10-18539422-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_201596.3(CACNB2):​c.1681G>T​(p.Glu561*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. E561E) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 30)

Consequence

CACNB2
NM_201596.3 stop_gained

Scores

5
1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 9.06

Publications

2 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.1681G>Tp.Glu561*
stop_gained
Exon 14 of 14NP_963890.2Q08289-1
CACNB2
NM_201590.3
MANE Plus Clinical
c.1519G>Tp.Glu507*
stop_gained
Exon 13 of 13NP_963884.2Q08289-3
CACNB2
NM_201597.3
c.1609G>Tp.Glu537*
stop_gained
Exon 14 of 14NP_963891.1Q08289-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.1681G>Tp.Glu561*
stop_gained
Exon 14 of 14ENSP00000320025.8Q08289-1
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.1519G>Tp.Glu507*
stop_gained
Exon 13 of 13ENSP00000366546.4Q08289-3
CACNB2
ENST00000352115.10
TSL:1
c.1609G>Tp.Glu537*
stop_gained
Exon 14 of 14ENSP00000344474.6Q08289-8

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.0000263
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.66
CADD
Pathogenic
46
DANN
Uncertain
1.0
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
1.0
D
PhyloP100
9.1
Vest4
0.87
GERP RS
5.9
Mutation Taster
=27/173
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199714857; hg19: chr10-18828351; API